Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-3073

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-3073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353073)

Label (Lbl713353073)
Packaging label for Ondansetron Orally Disintegrating Tablets USP 8 mg by Bryant Ranch Prepack. The label includes the product NDC 71335-3073-1, states it contains 30 tablets, and notes manufacture by Aurobindo Pharma Limited. It features dosage storage instructions, handling warnings, and two QR codes for package and dosage information.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron, an active pharmaceutical ingredient, showing the characteristic indole and imidazole rings along with methyl and ketone functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.